Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Roden

Showing results (141-150 of 684) with videos related to

Pageof 69
Sort By:
Nature Reviews. Drug Discovery|June 6, 2022
Thinking outside the box: non-canonical targets in multiple sclerosisLaura Bierhansl, Hans-Peter Hartung, Orhan Aktas, et al.
Acta Diabetologica|July 25, 2022
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient dataOliver Kuss, Cihan Akbulut, Sabrina Schlesinger, et al.
Diabetologia|July 5, 2016
Metabolic flexibility and oxidative capacity independently associate with insulin sensitivity in individuals with newly diagnosed type 2 diabetesMaria Apostolopoulou, Klaus Strassburger, Christian Herder, et al.
BMJ Open|September 10, 2020
Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experimentJana Sommer, Jan Dyczmons, Sandra Grobosch, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|December 20, 2007
Muscular mitochondrial dysfunction and type 2 diabetes mellitusVera B Schrauwen-Hinderling, Michael Roden, M Eline Kooi, et al.
Atherosclerosis|February 22, 2011
Interleukin-6 in the prediction of primary cardiovascular events in diabetes patients: results from the ESTHER studyChristian Herder, Ben Schöttker, Dietrich Rothenbacher, et al.
Psychotherapy and Psychosomatics|December 7, 2021
Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes: Results of a Randomized Controlled Trial (ECCE HOMO Study)Andreas Schmitt, Bernhard Kulzer, André Reimer, et al.
Diabetologia|June 20, 2023
How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trialsOliver Kuss, Marie Elisabeth Opitz, Lea Verena Brandstetter, et al.
Brain : a Journal of Neurology|September 9, 2021
Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 yearsDan Ziegler, Gidon J Bönhof, Alexander Strom, et al.
Molecular Medicine (Cambridge, Mass.)|November 25, 2010
Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndromeThomas C Wascher, Jan H N Lindeman, Harald Sourij, et al.
Pageof 69

Showing results (141-150 of 684) with videos related to

Sort By:
Pageof 69
Nature Reviews. Drug Discovery|June 6, 2022
Thinking outside the box: non-canonical targets in multiple sclerosisLaura Bierhansl, Hans-Peter Hartung, Orhan Aktas, et al.
Acta Diabetologica|July 25, 2022
Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient dataOliver Kuss, Cihan Akbulut, Sabrina Schlesinger, et al.
Diabetologia|July 5, 2016
Metabolic flexibility and oxidative capacity independently associate with insulin sensitivity in individuals with newly diagnosed type 2 diabetesMaria Apostolopoulou, Klaus Strassburger, Christian Herder, et al.
BMJ Open|September 10, 2020
Preferences of people with type 2 diabetes for telemedical lifestyle programmes in Germany: protocol of a discrete choice experimentJana Sommer, Jan Dyczmons, Sandra Grobosch, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|December 20, 2007
Muscular mitochondrial dysfunction and type 2 diabetes mellitusVera B Schrauwen-Hinderling, Michael Roden, M Eline Kooi, et al.
Atherosclerosis|February 22, 2011
Interleukin-6 in the prediction of primary cardiovascular events in diabetes patients: results from the ESTHER studyChristian Herder, Ben Schöttker, Dietrich Rothenbacher, et al.
Psychotherapy and Psychosomatics|December 7, 2021
Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes: Results of a Randomized Controlled Trial (ECCE HOMO Study)Andreas Schmitt, Bernhard Kulzer, André Reimer, et al.
Diabetologia|June 20, 2023
How amenable is type 2 diabetes treatment for precision diabetology? A meta-regression of glycaemic control data from 174 randomised trialsOliver Kuss, Marie Elisabeth Opitz, Lea Verena Brandstetter, et al.
Brain : a Journal of Neurology|September 9, 2021
Progression and regression of nerve fibre pathology and dysfunction early in diabetes over 5 yearsDan Ziegler, Gidon J Bönhof, Alexander Strom, et al.
Molecular Medicine (Cambridge, Mass.)|November 25, 2010
Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndromeThomas C Wascher, Jan H N Lindeman, Harald Sourij, et al.
Pageof 69